Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease.

Trial Profile

Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2013

At a glance

  • Drugs Eprosartan (Primary) ; Losartan (Primary) ; Propranolol (Primary)
  • Indications Angina pectoris; Arrhythmias; Cluster headache; Essential hypertension; Heart failure; Hypertension; Migraine; Tension type headache
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top